Qiagen N.V. (QGEN)

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medical Products	2.09B	1.98B	1.97B	2.14B	2.25B
Medical Products Growth	5.65%	0.66%	-8.23%	-4.89%	20.39%
Total	2.09B	1.98B	1.97B	2.14B	2.25B
Total Growth	5.65%	0.66%	-8.23%	-4.89%	20.39%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Americas	1.09B	-	-	-	-
Europe, Middle East and Africa	713.00M	648.49M	624.57M	733.47M	814.42M
Europe, Middle East and Africa Growth	9.95%	3.83%	-14.85%	-9.94%	19.37%
Asia Pacific, Japan and Rest of World	291.00M	298.15M	320.68M	410.29M	429.86M
Asia Pacific, Japan and Rest of World Growth	-2.40%	-7.03%	-21.84%	-4.55%	18.55%
United States	-	942.01M	935.28M	909.62M	909.69M
United States Growth	-	0.72%	2.82%	-0.01%	24.86%
Other Americas	-	89.56M	84.77M	88.14M	97.69M
Other Americas Growth	-	5.64%	-3.82%	-9.77%	0.83%
Total	2.09B	1.98B	1.97B	2.14B	2.25B
Total Growth	5.70%	0.66%	-8.23%	-4.89%	20.39%

Source: S&P Global Market Intelligence.